X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (351) 351
Publication (29) 29
Patent (10) 10
Conference Proceeding (3) 3
Newspaper Article (2) 2
Book Review (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (143) 143
index medicus (115) 115
female (105) 105
male (103) 103
adult (102) 102
infectious diseases (82) 82
hiv infections - drug therapy (72) 72
middle aged (71) 71
microbiology (43) 43
immunology (42) 42
hiv (37) 37
hiv infections - virology (35) 35
human immunodeficiency virus--hiv (34) 34
viral load (34) 34
virology (34) 34
treatment outcome (30) 30
aids (29) 29
anti-hiv agents - therapeutic use (29) 29
hiv-1 - drug effects (29) 29
hiv infections - complications (28) 28
pharmacology & pharmacy (25) 25
antiretroviral therapy (24) 24
prospective studies (24) 24
hiv infection (23) 23
antiretroviral drugs (22) 22
biochemistry & molecular biology (22) 22
cd4 lymphocyte count (22) 22
mutation (22) 22
research (22) 22
anti-hiv agents - administration & dosage (21) 21
chemistry, physical (21) 21
hiv-1 - genetics (21) 21
risk factors (21) 21
antiretroviral therapy, highly active (20) 20
efficacy (20) 20
therapy (20) 20
yeast (20) 20
anti-hiv agents - adverse effects (19) 19
analysis (18) 18
saccharomyces cerevisiae - genetics (18) 18
active antiretroviral therapy (17) 17
cell cycle (17) 17
drug therapy (17) 17
hiv infections - immunology (17) 17
rna, viral - blood (17) 17
saccharomyces cerevisiae - metabolism (17) 17
cohort studies (16) 16
hiv-1 - isolation & purification (16) 16
hiv-infected patients (16) 16
ritonavir - therapeutic use (16) 16
saccharomyces-cerevisiae (16) 16
tenofovir (16) 16
aged (15) 15
anti-hiv agents - pharmacology (15) 15
clinical trials (15) 15
hiv protease inhibitors - therapeutic use (15) 15
hiv-1-infected patients (15) 15
human-immunodeficiency-virus (15) 15
infection (15) 15
psychiatry (15) 15
saccharomyces cerevisiae (15) 15
safety (15) 15
spain (15) 15
treatment failure (15) 15
care and treatment (14) 14
drug therapy, combination (14) 14
health aspects (14) 14
highly active antiretroviral therapy (14) 14
hiv-1 (14) 14
prevalence (14) 14
protease inhibitors (14) 14
young adult (14) 14
aids/hiv (13) 13
chemisorption (13) 13
time factors (13) 13
animals (12) 12
antiretroviral treatment (12) 12
cell biology (12) 12
drug resistance (12) 12
drug resistance, viral (12) 12
human immunodeficiency virus (12) 12
infections (12) 12
medicine (12) 12
multidisciplinary sciences (12) 12
retrospective studies (12) 12
antiretroviral agents (11) 11
cancer (11) 11
double-blind (11) 11
efavirenz (11) 11
patients (11) 11
phosphorylation (11) 11
platinum (11) 11
raltegravir (11) 11
research article (11) 11
ritonavir (11) 11
saccharomyces cerevisiae proteins - metabolism (11) 11
adsorption (10) 10
antiviral agents (10) 10
combination (10) 10
cross-sectional studies (10) 10
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Medicine, ISSN 1078-8956, 04/2010, Volume 16, Issue 4, pp. 460 - 465
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2014, Volume 9, Issue 12, p. e114142
Background: HIV-1 infection increases plasma levels of inflammatory markers. Combination antiretroviral therapy (cART) does not restore inflammatory markers to... 
CONTROLLED-TRIAL | ACTIVATION | CD4 | T-CELL RECOVERY | MULTIDISCIPLINARY SCIENCES | ANTIRETROVIRAL THERAPY | MICROBIAL TRANSLOCATION | SIV INFECTION | RALTEGRAVIR INTENSIFICATION | PROTEASE INHIBITORS | D-DIMER | HIV Infections - blood | Prospective Studies | Humans | Middle Aged | Raltegravir Potassium - administration & dosage | Raltegravir Potassium - therapeutic use | Male | Biomarkers - blood | HIV Integrase Inhibitors - administration & dosage | Inflammation - blood | HIV Infections - immunology | HIV Integrase Inhibitors - therapeutic use | Adult | Female | HIV Infections - drug therapy | Usage | HIV patients | Inflammation | T cells | HIV (Viruses) | Infection | Highly active antiretroviral therapy | Protease inhibitors | Proteases | Analysis | Hepatitis C virus | Health aspects | HIV infection | Antiretroviral drugs | Composition | CD8 antigen | Markers | Lymphocytes T | Proteinase inhibitors | T cell receptors | Infections | Patients | Antiretroviral therapy | CD4 antigen | Amplification | Cell activation | Acquired immune deficiency syndrome--AIDS | Lymphocytes | Antiretroviral agents | Integrals | Human immunodeficiency virus--HIV | Replication | Sampling methods | Plasma levels | Dimers | Antiretrovirals | HIV infections | Inflamació | Marcadors bioquímics | Infeccions per VIH | Biochemical markers | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
Journal Article
Journal Article
Journal Article
ClinicoEconomics and Outcomes Research, ISSN 1178-6981, 2013, Volume 5, Issue 1, pp. 215 - 221
The current economic recession in European countries has forced governments to design emergency measures to reduce spending on drugs, including antiretroviral... 
Health economics | Antiretroviral therapy highly active | Cost analysis | Protease inhibitor monotherapy | Antiretroviral agents economics | Highly active antiretroviral therapy | Care and treatment | Economic aspects | Research | HIV infection | Medical economics | Methods | Drug therapy | Antiretroviral drugs
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2015, Volume 10, Issue 6, pp. e0128131 - e0128131
Journal Article
PLoS Pathogens, ISSN 1553-7366, 10/2011, Volume 7, Issue 10, p. e1002314
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2014, Volume 9, Issue 1, p. e84683
Journal Article
PLOS ONE, ISSN 1932-6203, 06/2019, Volume 14, Issue 6, p. e0218531
Journal Article